Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 97% ee. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover high-yield, enantioselective chiral indoloindolizidine synthesis with 97%+ ee. Solve supply chain risks for anti-cancer/antiviral drug development.
Solve low enantioselectivity & high catalyst cost in alpha-hydroxy-beta-keto ester production. 97% ee, 95% yield, 5-25 mol% catalyst. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.